Overall rank by patents
#25,495
Across all tracked assignees
USPTO PatentsView assignee record - 11 granted patents across 19 technology areas, active 2020–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G21F (PROTECTION AGAINST X-RADIATION, GAMMA RADIATION, CORPUSCULAR RADIATION OR PARTICLE BOMBARDMENT; TREATING RADIOACTIVELY CONTAMINATED MATERIAL; DECONTAMINATION ARRANGEMENTS THEREFOR).
The verdict
Veolia holds 11 US patents across 19 technology areas, rank #25,495 of 50,000 tracked assignees.
Veolia Nuclear Solutions, Inc. has been granted 11 US utility patents between 2020 and 2024, placing Veolia Nuclear Solutions, Inc. at rank #25,495 across all assignees tracked by PlainPatent. This portfolio spans 19 distinct Cooperative Patent Classification (CPC) subclasses, averaging 20.7 claims per patent with primary concentration in G21F (PROTECTION AGAINST X-RADIATION, GAMMA RADIATION, CORPUSCULAR RADIATION OR PARTICLE BOMBARDMENT; TREATING RADIOACTIVELY CONTAMINATED MATERIAL; DECONTAMINATION ARRANGEMENTS THEREFOR). As a US Corporation, Veolia Nuclear Solutions, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Veolia sits between Vanguard Group, Inc. (11 patents, rank #25,491) and Viking Pump, Inc. (11 patents, rank #25,499) - the closest US assignees by grant volume. The composite Innovation Score of 42.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2020 through 2024, with 11 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Veolia Nuclear Solutions, Inc.'s 20.7 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 19 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Veolia Nuclear Solutions, Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Vanguard Group, Inc.
11 patents
Vascular Access Technologies, Inc.
11 patents
Vascular Graft Solutions Ltd.
11 patents
Ventus Therapeutics U.S., Inc.
11 patents
Versana Micro Inc.
11 patents
Verwer Dahlias B.V.
11 patents
Viega GmbH & Co. KG
11 patents
Viking Pump, Inc.
11 patents
Veolia Nuclear Solutions, Inc.
11 patents
What this shows Veolia holds 11 patents at rank #25,495, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Veolia's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
42 Top 32% higher than 68% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 1 | 9.1% |
| 2021 | 5 | 45.5% |
| 2022 | 1 | 9.1% |
| 2023 | 3 | 27.3% |
| 2024 | 1 | 9.1% |
Top 15 of 19 technology areas
Overall rank by patents
#25,495
Across all tracked assignees
42.0 out of 100
How to use this portfolio
Veolia's 11 grants land it in the top 32% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.